Stock Analysis
Kimberly-Clark Corp.KMB
P/E 17.96×· 5Y range 14.60–56.17×· bottom 20% of history
Sector: Basic Materials · Industry: Converted Paper & Paperboard Prods (No Contaners/Boxes)
AnalystsHold21 analystsP/E 18.0× sits at the 20th percentile of its 5.0978781656399725-year history.
Cash covers 15% of debt · Q2 2026.
PMP Verdict
Mixed fundamentals, cheap valuation
Strengths
- Profitability90
- Quality87
Risks
- Growth37
Mixed business trading cheap — priced for skepticism.
Bull Case
- ✓ROE 104.3% — efficient capital deployment
- ✓Interest coverage 12.5× — debt well covered
- ✓P/E 18.0× at bottom 20% of 5-year history
What's happening with KMB
Profile
Strong profitability, earnings quality, moat and valuation; growth lags behind.
How is each axis scored?
- Valuation77/100 · Strong
- P/E vs own history (20th pct)25/25
- FCF yield (5.2%)20/25
- P/S (2.1x)20/25
- EV/EBIT (16.2x)12/25
- Growth37/100 · Weak
- Revenue CAGR (-4.0%)0/25
- Net income CAGR (2.7%)6/25
- EPS CAGR 5Y (3.2%)6/25
- Fwd implied growth (34.9%)25/25
- Profitability90/100 · Strong
- ROIC (26.6%)25/25
- ROE (104.3%)25/25
- Net margin (11.8%)20/25
- Operating margin (15.2%)20/25
- Financial Health54/100 · Moderate
- Altman Z (2.64)18/25
- Current ratio (0.91)6/25
- Interest coverage (12.5x)25/25
- Net cash / debt (D/A 30%)5/25
- Quality87/100 · Strong
- Piotroski F (6/9)15/25
- Beneish M (-2.53)25/25
- FCF conversion (93%)22/25
- Margin stability (σ 3.4%)25/25
- Moat81/100 · Strong
- ROIC >12% years (10/10 yrs)25/25
- Median gross margin (35.1%)13/25
- FCF-positive years (10/10 yrs)25/25
- Worst-year net margin (worst 7.6%)18/25
Risk Flags
- ⚠Revenue shrinking 4.0%/yr
About Kimberly-Clark Corp.
With more than half of its sales from personal care and another third from consumer tissue products, Kimberly-Clark is a leading manufacturer in the tissue and hygiene realm. Show more
Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates in the professional segment, partnering with businesses to provide workplace safety and sanitation solutions. Kimberly-Clark generates just over half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America. It is slated to add Kenvue's consumer health portfolio to its mix in the second half of calendar year 2026.
Headquarters: IRVING, TX · Employees: 36,000 · Website ↗
Price History
Weekly Candlestick Chart — up to 5Y
Key Metrics
Financial snapshot · Tap any metric for its definition and grade
TTM Snapshot
trailing twelve months · YoYValuation
77B+P/E (TTM)17.9xB
Grade B: FairPrice / TTM EPS (own statements) — vs own 5Y history: 14.6x–56.2x · 20th pct
P/FCF19.0xB
Grade B: FairPrice / Free Cash Flow per share (Finnhub). Inverse of FCF yield — negative when FCF is negative
FCF Yield5.2%A
Grade A: ValueTTM (OCF − CapEx) / Market Cap — vs own 5Y history: 2.6%–6.4% · 77th pct
P/S (TTM)2.12xB
Grade B: FairPrice / TTM Revenue (own statements) — vs own 5Y history: 1.9x–4.5x · 19th pct
EV/EBIT16.2xB
Grade B: FairEnterprise value / TTM EBIT (D&A not in our data) — capital-structure neutral — vs own 5Y history: 13.5x–44.0x · 11th pct
EV/Sales2.4xB
Grade B: FairEnterprise Value / TTM Revenue (Finnhub) — capital-structure neutral sales multiple
Forward P/E13.3xA
Grade A: CheapPrice / next-year EPS estimate — shows whether the TTM multiple is rich or just front-loading growth
P/B Ratio18.72xD
Grade D: Very expensivePrice to Book Value. Neg. equity = heavy buybacks
PEG Ratio11.73D
Grade D: ExpensiveFinnhub PEG — their P/E basis ÷ expected EPS growth. Suppressed when their P/E diverges >2× from our TTM P/E (different basis)
Dividend Yield4.85%A
Grade A: PaysTTM dividend yield (Finnhub) — annual dividends / price. None = no dividend; very high yield can signal distress
Payout Ratio85.9%C
Grade C: HighDividends / Net Income (Finnhub) — share of earnings paid out; >90% or negative = unsustainable
Profitability
90A+ROIC26.6%A
Grade A: MoatNOPAT (EBIT less ~21% tax) / invested capital (equity + debt − cash). Flagship quality metric — durable >15% signals a moat
ROE104.3%A
Grade A: StrongReturn on Equity. Neg. equity = heavy buybacks
ROA11.2%A
Grade A: StrongReturn on Assets (Finnhub) — Net Income / Total Assets; how efficiently assets produce profit
Net Margin11.8%A
Grade A: HighNet Income / Revenue
Operating Margin15.2%C
Grade C: AverageTTM EBIT / TTM Revenue
Gross Margin36.8%C
Grade C: AverageGross Profit / Revenue
FCF Margin11.0%C
Grade C: AverageFCF / Revenue
True FCF Margin10.2%C
Grade C: AverageTTM (OCF − CapEx − SBC) / TTM Revenue — SBC treated as a real cost
Growth
37DRevenue CAGR-4.0%D
Grade D: LowCompound annual revenue growth (up to 5Y depending on data availability)
Net Income CAGR2.7%D
Grade D: LowCompound annual net income growth (up to 5Y depending on data availability)
EPS CAGR (5Y)3.2%D
Grade D: LowCompound annual EPS growth over up to 5Y of per-share earnings (own statements). Null when either endpoint EPS ≤ 0
Implied EPS Growth34.9%A
Grade A: HighAnalyst forward EPS (normalized basis) vs our GAAP TTM EPS — different bases, so extreme values usually mark cyclically depressed TTM earnings, not real growth
Dilution (5Y)-1.7%B
Grade B: FlatShare count change over 5Y
SBC / Net Income6.7%A
Grade A: LowStock-based comp/Net income. >30% = dilution risk
SBC / Revenue0.8%A
Grade A: LowTTM stock-based comp / TTM Revenue
Financial Health
54CAltman Z-Score2.64C
Grade C: Gray zoneBankruptcy risk. >3 Safe, <1.8 Distress
Current Ratio0.91xD
Grade D: LowCurrent Assets/Liabilities
Quick Ratio0.69xC
Grade C: Ok(Current Assets − Inventory) / Current Liabilities (Finnhub) — stricter liquidity test, excludes inventory
Interest Coverage12.5xA
Grade A: StrongEBIT/Interest. >10 Strong
Debt Repayment3.1yC
Grade C: AverageYears to repay net debt via FCF
Net Debt/EBIT2.2xC
Grade C: MedLeverage. <2x Low, >4x High
Debt/Equity3.49xD
Grade D: HighDebt / Equity: <1 Conservative, >2 Risky. Not meaningful with non-positive equity; shown as unavailable rather than low debt.
Cash / Debt0.15xD
Grade D: ThinCash covers how much of total debt. >1 = could repay all debt from cash
Quality
87APiotroski F-Score6/9C
Grade C: AverageFinancial strength 0–9. >7 Strong
Beneish M-Score-2.53A
Grade A: SafeEarnings manipulation risk. < -2.22 Safe
FCF Conversion93.1%A
Grade A: StrongFCF / Net Income
Margin Stability3.4%A
Grade A: StableEBIT margin std deviation. Lower = stable
Capex / Revenue9.1%C
Grade C: AverageTTM CapEx / TTM Revenue — high % = capital-hungry business
Asset Turnover0.95xC
Grade C: AverageRevenue / Total Assets (Finnhub) — how efficiently the asset base generates sales
Insider Transactions
SEC Form 4 · 8 recordsP/S codes are the directional signal; grants, option exercises and tax withholding carry none. Form 4 doesn't flag 10b5-1 plans — scheduled sales may appear within open-market sells.
| Trade date | Insider | Transaction | Shares | Filed |
|---|---|---|---|---|
Corsi Patricia Filed | Corsi Patricia | Option exercise | -966 | |
Corsi Patricia Filed | Corsi Patricia | Tax withholding | -404 | |
Corsi Patricia Filed | Corsi Patricia | Option exercise | +966 | |
Slavtcheff Craig Filed | Slavtcheff Craig | Option exercise | -1255 | |
Slavtcheff Craig Filed | Slavtcheff Craig | Option exercise | -4024 |
Show 3 more filingsShow fewer filings
| Trade date | Insider | Transaction | Shares | Filed |
|---|---|---|---|---|
Slavtcheff Craig Filed | Slavtcheff Craig | Tax withholding | -1711 | |
Slavtcheff Craig Filed | Slavtcheff Craig | Tax withholding | -534 | |
Slavtcheff Craig Filed | Slavtcheff Craig | Option exercise | +1.3K |
Option exercise (M) rows report a derivative leg, not an open-market sale — a paired negative entry is the option position being consumed.
More metrics — Moat, Per Share, Balance Sheet, MarketHide additional metrics
Moat
81AROIC >12% Years10/10 yrsA
Grade A: DurableShare of completed fiscal years with ROIC > 12% — measures multi-year capital-return durability
Gross Margin (Med.)35.1%C
Grade C: ModerateMedian annual gross margin across available fiscal years — pricing-power durability
FCF-Positive Years10/10 yrsA
Grade A: DurableShare of completed fiscal years with positive free cash flow
Net Margin Floor7.6%A
Grade A: DurableWeakest annual net margin across completed fiscal years — recession/downcycle resilience
Per Share
EPS (TTM)$5.88
Own TTM net income / shares — same earnings basis as P/E
Cash / Share$2.87
Cash & short-term investments per share (Finnhub)
Book Value / Share$5.26
Shareholders' equity per share (Finnhub). Negative = accumulated losses / heavy buybacks
Balance Sheet
Total Debt$6.54B
Total debt obligations (short + long term)
Cash & Equiv.$956.00M
Cash and short-term investments
Net Debt$5.58B
Total Debt minus Cash. Negative = Net Cash position
Total Equity$1.87B
Shareholders' equity (book value)
Asset / Liability1.11xC
Grade C: AdequateTotal Assets / Total Liabilities
Market
Market Cap$35.09B
Current Market Capitalization
Beta0.30B
Grade B: DefensivePrice sensitivity vs the market (Finnhub) — 1.0 moves with market, >1.2 amplifies swings
How grades work: each metric is graded A–D against fixed thresholds (tap a row for the meaning). Card grades map the pillar score to A+–E — a card grade is that pillar's own score, not an average of the rows shown.
Financials as of Jun 2026 · Ratio snapshot Oct 16, 2026
Key Insights: Kimberly-Clark Corp. (KMB)
KMB is up 1.44% at the last close. Piotroski F-Score of 6/9 indicates mixed fundamentals for Kimberly-Clark Corp.. Altman Z-Score of 2.64 falls in the grey zone (1.81–2.99) — financial distress is unlikely but not ruled out. Beneish M-Score of -2.53 suggests a low likelihood of earnings manipulation. Revenue has been contracting (CAGR ≈ -4%), which weighs on the growth outlook.
- Takes ~3.1 years to repay net debt from free cash flow.
- At a valuation score of 77/100, KMB trades near the cheapest end of its own historical range (P/E 17.9).
- Return on equity of 104.3% is well above the market average.
- The stock currently yields 4.8% in dividends.
See how KMB ranks on the Capex Tracker — top 50 capital spenders compared.
Recent Market Moves
See all KMB moves →| Date | Session | Price | Move | Z-Score |
|---|---|---|---|---|
| Oct 15 | Pre-market | 102.75 | +3.36% | 2.79 |
| Oct 15 | Regular | 103.27 | +3.88% | 3.22 |
| Oct 15 | After-hours | 104.26 | +4.88% | 4.05 |
Frequently Asked Questions about KMB
What is the current Kimberly-Clark Corp. (KMB) stock price?
KMB is trading at $105.57 at the last market close, up 1.44% on the session. PreMarketPrice tracks KMB pre-market, intraday and after-hours prices.
Is KMB stock a buy right now?
PreMarketPrice's quantitative model rates Kimberly-Clark Corp.'s financial health at 54/100. This is a data-driven snapshot of fundamentals, not investment advice.
Is KMB stock overvalued?
Kimberly-Clark Corp. trades at a trailing P/E of 17.9 and our valuation score rates it 77/100 (higher = cheaper vs. its own history). See the Valuation History and Key Metrics sections for forward P/E, EV/EBITDA and PEG context.
When does Kimberly-Clark Corp. report earnings?
No confirmed earnings date is currently scheduled for KMB. The Earnings section lists recent reports and updates as dates are announced.
What sector does Kimberly-Clark Corp. operate in?
Kimberly-Clark Corp. operates in the Basic Materials sector, within the Converted Paper & Paperboard Prods (No Contaners/Boxes) industry. The Related Stocks section lists sector peers for comparison.
What does Kimberly-Clark Corp. do?
With more than half of its sales from personal care and another third from consumer tissue products, Kimberly-Clark is a leading manufacturer in the tissue and hygiene realm.
About Kimberly-Clark Corp. (KMB) Stock
Kimberly-Clark Corp. (KMB) is a US-listed stock operating in the Basic Materials sector, specifically the Converted Paper & Paperboard Prods (No Contaners/Boxes) industry. As of the latest update, Kimberly-Clark Corp. is trading at $105.57, up 1.44% on the day with a market capitalization of $35.1 billion. The financial health score for KMB is 54/100, which indicates moderate financial strength based on profitability, leverage, liquidity, and growth metrics. This page provides real-time pre-market pricing, earnings calendar, financial health analysis, and valuation metrics for KMB stock.
KMB Stock Analysis & Key Metrics
On PreMarketPrice, you can track Kimberly-Clark Corp. (KMB) across multiple dimensions:
- Pre-market price & movement: Real-time KMB stock price with percentage change, updated continuously during pre-market and regular trading hours.
- Valuation & P/E history: Historical P/E, P/S, and P/B ratios for KMB with trend analysis and normalized valuation multiples.
- Financial statements: Revenue, net income, assets, liabilities, and equity for Kimberly-Clark Corp. across multiple reporting periods.
- Financial health score: A composite score of 54/100 based on Altman Z-Score, Piotroski F-Score, profitability, and leverage metrics for KMB.
- Sector peers: Compare KMB against 4 other basic materials stocks on key financial metrics.
Is KMB a Good Stock to Buy?
This page provides data-driven analysis to help you evaluate Kimberly-Clark Corp. (KMB) as an investment. The financial health score of 54/100 suggests moderate financial fundamentals. Valuation metrics show whether the stock is trading above or below its historical average.However, this is not financial advice — always do your own research before investing.
Data on this page is sourced from real-time market feeds, Polygon.io, and Finnhub.Kimberly-Clark Corp. (KMB) trades on NYSE/NASDAQ. Pre-market trading occurs 4:00 AM – 9:30 AM ET. Regular market hours are 9:30 AM – 4:00 PM ET.